Cellogen Therapeutics Secures ₹20 Cr to Pioneer Affordable CAR-T Cancer Therapy in India
In a significant vote of confidence for India’s deep-tech biotech sector, Cellogen Therapeutics has raised ₹20 crore (approximately $2 million) in a fresh funding round.…